GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for Q2 of FY2409-11-2023
09-11-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release to the Analyst/Investors for Q2 of FY2409-11-2023
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Outcome Of The Board Meeting Dated November 09, 2023
Outcome of the Board meeting dated November 09, 202309-11-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Preponement of earnings call meet for Q2 and half year of FY24.31-10-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of earnings call meet for Q2 and half year of FY24.30-10-2023
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for Consider And Approval Of The Un-Audited Financial Results For The Second Quarter And Half Year Ended On September 30, 2023
GRANULES INDIA LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve the un-audited financial results for the second quarter and half year ended on September 30, 202327-10-2023
Granules India gets USFDA nod for generic drug used for short-term treatment of heartburn
The approval by the US Food Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules of strengths 20 mg and 40 mg, Granules India said in a regulatory filing.19-10-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited received ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules19-10-2023
Granules India gets USFDA approval for hypertension drug; share price gains
Losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension to lower blood pressure and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.03-10-2023
Granules India gets USFDA's nod for hypertension generic
It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Hyzaar Tablets of Organon LLC30-09-2023